Breaking News Instant updates and real-time market news.

SNY

Sanofi

$47.26 /

-0.05 (-0.11%)

, REGN

Regeneron

$545.22 /

-24.72 (-4.34%)

19:39
05/26/20
05/26
19:39
05/26/20
19:39

Sanofi's offering of Regeneron stock prices at $515 per share, Bloomberg says

SNY

Sanofi

$47.26 /

-0.05 (-0.11%)

REGN

Regeneron

$545.22 /

-24.72 (-4.34%)

  • 26

    May

  • 29

    May

  • 12

    Jun

  • 25

    Oct

  • 27

    May

SNY Sanofi
$47.26 /

-0.05 (-0.11%)

05/26/20 UBS
Sanofi price target lowered to EUR 101 from EUR 103 at UBS
05/26/20 Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
05/26/20 SVB Leerink
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink
05/12/20 Oppenheimer
Novavax price target raised to $38.50 from $19 at Oppenheimer
REGN Regeneron
$545.22 /

-24.72 (-4.34%)

05/26/20
Fly Intel: Top five analyst upgrades
05/26/20 RBC Capital
BioMarin among Sanofi's most intriguing potential targets, says RBC Capital

TODAY'S FREE FLY STORIES

Downgrade
Netflix downgraded to In-Line from Outperform at Imperial Capital » 04:58
07/06/20
07/06
04:58
07/06/20
04:58
NFLX

Netflix

$476.31 /

-9.47 (-1.95%)

Imperial Capital analyst…

Imperial Capital analyst David Miller downgraded Netflix to In-Line from Outperform with an unchanged price target of $489. The stock closed Thursday down $8.75 to $476.89. The shares are up over 50% since January 2, Miller tells investors in a research note. As a result, the analyst sees only an additional 2.5% upside in Netflix. He cites valuation for the downgrade to In-Line.

ShowHide Related Items >><<
NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/30/20 Cowen
Netflix price target raised to $535 from $485 at Cowen
06/23/20 JPMorgan
Netflix user growth implies upside to Q2 guidance, says JPMorgan
06/18/20 Imperial Capital
Netflix price target raised to $489 from $485 at Imperial Capital
NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

NFLX Netflix
$476.31 /

-9.47 (-1.95%)

Upgrade
Xilinx upgraded to Conviction Buy from Buy at Goldman Sachs » 04:56
07/06/20
07/06
04:56
07/06/20
04:56
XLNX

Xilinx

$95.29 /

+2.01 (+2.15%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

06/30/20 SunTrust
Xilinx price target raised to $104 from $93 at SunTrust
06/30/20 Susquehanna
Xilinx price target raised to $115 from $105 at Susquehanna
06/30/20 JPMorgan
Xilinx price target raised to $88 from $85 at JPMorgan
06/30/20 Morgan Stanley
Xilinx trends less negative than feared, says Morgan Stanley
XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

XLNX Xilinx
$95.29 /

+2.01 (+2.15%)

Conference/Events
Cantor Fitzgerald healthcare analysts to hold analyst/industry conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

Specialty Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
NetApp management to meet virtually with Oppenheimer » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
NTAP

NetApp

$43.57 /

+0.08 (+0.18%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

06/26/20
Fly Intel: Top five analyst upgrades
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/26/20 BofA
NetApp upgraded to Buy from Neutral at BofA
06/18/20 Deutsche Bank
NetApp initiated with a Hold at Deutsche Bank
NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

NTAP NetApp
$43.57 /

+0.08 (+0.18%)

Conference/Events
Cloudera participates in a conference call with JMP Securities » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
CLDR

Cloudera

$12.28 /

-0.1 (-0.81%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

06/10/20 Morgan Stanley
Morgan Stanley says Cloudera could be valued at $14.50 using typical PE multiple
06/09/20 DA Davidson
DA Davidson says Cloudera sale 'increasingly likely,' IBM seen as possible buyer
06/09/20 Northland
Northland downgrades Cloudera to Market Perform as coverage transferred
06/03/20
Fly Intel: Top five analyst upgrades
CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

CLDR Cloudera
$12.28 /

-0.1 (-0.81%)

Conference/Events
UBS leisure, gaming & lodging analyst to hold analyst/industry conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

Leisure, Gaming &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
3-Month Bill Auction to be released at 11:30  04:55
07/06/20
07/06
04:55
07/06/20
04:55
 
General news
PMI Services Index Level to be reported at 09:45 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June PMI Services Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Biohaven Pharmaceutical management to meet virtually with Piper Sandler » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
BHVN

Biohaven Pharmaceutical

$71.19 /

-1.075 (-1.49%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
06/24/20 Piper Sandler
Piper Sandler stays Overweight Biohaven after troriluzole efficacy signal in OCD
06/23/20 Cantor Fitzgerald
Biohaven Pharmaceutical price target raised to $109 from $82 at Cantor Fitzgerald
06/19/20 Piper Sandler
Biohaven launch of Nurtec continues to impress, says Piper Sandler
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

Conference/Events
Hudson Pacific management to meet virtually with Piper Sandler » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
HPP

Hudson Pacific

$25.32 /

+0.03 (+0.12%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

06/26/20 Mizuho
Hudson Pacific shares could be worth $32-$40 with spinoff, says Mizuho
06/25/20
Fly Intel: Top five analyst downgrades
06/24/20 Morgan Stanley
Hudson Pacific cut to Equal Weight from Overweight at Morgan Stanley
04/16/20 Jefferies
Hudson Pacific initiated with a Hold at Jefferies
HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

HPP Hudson Pacific
$25.32 /

+0.03 (+0.12%)

General news
PMI Services Index Composite to be reported at 09:45 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June PMI Services Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
ObsEva to host conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
OBSV

ObsEva

$6.15 /

+0.17 (+2.84%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

03/24/20 Wedbush
ObsEva price target lowered to $34 from $40 at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 after pipeline update at Wedbush
03/05/20 Wedbush
ObsEva price target raised to $40 from $36 at Wedbush
12/19/19 H.C. Wainwright
ObsEva price target raised to $40 from $36 at H.C. Wainwright
OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

OBSV ObsEva
$6.15 /

+0.17 (+2.84%)

General news
ISM Non-Mfg Index Composite to be reported at 10:00 » 04:55
07/06/20
07/06
04:55
07/06/20
04:55

June ISM Non-Mfg Index…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Dominion Energy to hold a conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
BRK.A

Berkshire Hathaway

$267,661.14 /

+751.14 (+0.28%)

, D

Dominion

$82.68 /

+0.32 (+0.39%)

Management discusses the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
D Dominion
$82.68 /

+0.32 (+0.39%)

06/09/20 Seaport Global
Dominion initiated with a Buy at Seaport Global
05/29/20 Wolfe Research
Dominion downgraded to Peer Perform from Outperform at Wolfe Research
05/14/20 Credit Suisse
Dominion price target raised to $85 from $80 at Credit Suisse
04/24/20 Morgan Stanley
Federal support for renewables could come in summer, says Morgan Stanley
BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

D Dominion
$82.68 /

+0.32 (+0.39%)

BRK.A Berkshire Hathaway
$267,661.14 /

+751.14 (+0.28%)

D Dominion
$82.68 /

+0.32 (+0.39%)

D Dominion
$82.68 /

+0.32 (+0.39%)

General news
6-Month Bill Auction to be released at 11:30  04:55
07/06/20
07/06
04:55
07/06/20
04:55
 
Conference/Events
Immunomedics to host conference call » 04:55
07/06/20
07/06
04:55
07/06/20
04:55
IMMU

Immunomedics

$37.49 /

+0.55 (+1.49%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

07/01/20 BofA
BofA makes 14 additions, four deletions from US 1 list
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
05/29/20 Piper Sandler
Immunomedics' sacituzumab activity remains consistent, says Piper Sandler
05/28/20 H.C. Wainwright
Immunomedics CEO change to not impact Trodelvy launch, says H.C. Wainwright
IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

  • 29
    Apr
  • 05
    Dec
IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

IMMU Immunomedics
$37.49 /

+0.55 (+1.49%)

Downgrade
Intel downgraded to Sell from Neutral at Goldman Sachs » 04:53
07/06/20
07/06
04:53
07/06/20
04:53
INTC

Intel

$59.11 /

+0.31 (+0.53%)

Goldman Sachs analyst…

Goldman Sachs analyst Toshiya Hari downgraded Intel to Sell from Neutral with a price target of $54, down from $65. The stock closed Thursday up 32c to $59.13. Recent industry checks indicate a slowdown in PC builds in the second half of 2020 and continued share loss for Intel in the client and server central processing unit markets, Hari tells investors in a research note. As a result, the analyst cut 2021 and 2022 earnings estimates to below Street levels and sees 9% downside in Intel shares.

ShowHide Related Items >><<
INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

06/26/20 KeyBanc
Memory supply remains limited in 2H amid low visibility, says KeyBanc
06/23/20 Oppenheimer
Apple creating 'wide moat' for own ecosystem, says Oppenheimer
06/23/20 Goldman Sachs
Apple's revamped Mac rollout plans look aggressive, says Goldman Sachs
06/23/20 Raymond James
Apple's transition away from Intel to result in cost savings, says Raymond James
INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

INTC Intel
$59.11 /

+0.31 (+0.53%)

Downgrade
Globus Medical downgraded to Neutral from Overweight at Piper Sandler » 04:50
07/06/20
07/06
04:50
07/06/20
04:50
GMED

Globus Medical

$49.15 /

+0.58 (+1.19%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GMED Globus Medical
$49.15 /

+0.58 (+1.19%)

GMED Globus Medical
$49.15 /

+0.58 (+1.19%)

05/08/20 SVB Leerink
Globus Medical price target lowered to $56 from $63 at SVB Leerink
03/18/20 BTIG
Globus Medical upgraded to Buy from Neutral at BTIG
03/12/20 Piper Sandler
Globus Medical buyback 'nice vote of confidence,' says Piper Sandler
03/06/20 Credit Suisse
Globus Medical price target lowered to $59 from $67 at Credit Suisse
GMED Globus Medical
$49.15 /

+0.58 (+1.19%)

Initiation
Vroom initiated with an Outperform at Baird » 04:48
07/06/20
07/06
04:48
07/06/20
04:48
VRM

Vroom

$54.21 /

+0.045 (+0.08%)

Baird analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$54.21 /

+0.045 (+0.08%)

04:46 Today Stifel
Vroom initiated with a Buy at Stifel
07/05/20 Goldman Sachs
Vroom initiated with a Neutral at Goldman Sachs
07/05/20 William Blair
Vroom initiated with an Outperform at William Blair
06/09/20 Benchmark
Benchmark starts coverage of newly-public Vroom at Buy with $55 price target
  • 09
    Jun
VRM Vroom
$54.21 /

+0.045 (+0.08%)

VRM Vroom
$54.21 /

+0.045 (+0.08%)

Initiation
Vroom initiated with a Buy at Stifel » 04:46
07/06/20
07/06
04:46
07/06/20
04:46
VRM

Vroom

$54.21 /

+0.045 (+0.08%)

Stifel analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$54.21 /

+0.045 (+0.08%)

07/05/20 Goldman Sachs
Vroom initiated with a Neutral at Goldman Sachs
07/05/20 William Blair
Vroom initiated with an Outperform at William Blair
06/09/20 Benchmark
Benchmark starts coverage of newly-public Vroom at Buy with $55 price target
06/09/20 Benchmark
Vroom initiated with a Buy at Benchmark
  • 09
    Jun
VRM Vroom
$54.21 /

+0.045 (+0.08%)

VRM Vroom
$54.21 /

+0.045 (+0.08%)

Initiation
Srax initiated with a Buy at B. Riley FBR » 04:43
07/06/20
07/06
04:43
07/06/20
04:43
SRAX

Srax

$2.49 /

-0.075 (-2.93%)

B. Riley FBR initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRAX Srax
$2.49 /

-0.075 (-2.93%)

Upgrade
Marcus upgraded to Buy from Neutral at B. Riley FBR » 04:42
07/06/20
07/06
04:42
07/06/20
04:42
MCS

Marcus

$13.25 /

-0.26 (-1.92%)

B. Riley FBR analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCS Marcus
$13.25 /

-0.26 (-1.92%)

MCS Marcus
$13.25 /

-0.26 (-1.92%)

06/26/20 Benchmark
Marcus' recent weakness a buying opportunity, says Benchmark
04/17/20 B. Riley FBR
White House guidelines give some clarity to film exhibitors, says B. Riley FBR
04/15/20 Benchmark
Marcus upgraded to Buy on long-term optimism at Benchmark
04/15/20 Benchmark
Marcus upgraded to Buy from Hold at Benchmark
MCS Marcus
$13.25 /

-0.26 (-1.92%)

MCS Marcus
$13.25 /

-0.26 (-1.92%)

Downgrade
Boohoo downgraded to Hold from Buy at Liberum » 04:41
07/06/20
07/06
04:41
07/06/20
04:41
BHOOY

Boohoo

$0.00 /

+ (+0.00%)

Liberum analyst Wayne…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHOOY Boohoo
$0.00 /

+ (+0.00%)

06/25/20 Morgan Stanley
Boohoo price target raised to 190 GBp from 150 GBp at Morgan Stanley
06/24/20 Citi
Boohoo upgraded to Buy from Neutral at Citi
06/19/20 Credit Suisse
Boohoo price target raised to 440 GBp from 400 GBp at Credit Suisse
06/18/20 Barclays
Boohoo price target raised to 470 GBp from 425 GBp at Barclays
Downgrade
Associated British Foods downgraded to Neutral from Outperform at Exane » 04:40
07/06/20
07/06
04:40
07/06/20
04:40
ASBFY

Associated British Foods

$0.00 /

+ (+0.00%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASBFY Associated British Foods
$0.00 /

+ (+0.00%)

04:39 Today RBC Capital
Associated British Foods upgraded to Outperform from Sector Perform at RBC
07/03/20 Kepler Cheuvreux
Associated British Foods downgraded to Hold from Buy at Kepler Cheuvreux
07/03/20 Goldman Sachs
Associated British Foods downgraded to Neutral from Buy at Goldman Sachs
05/27/20 Credit Suisse
Associated British Foods price target lowered to 2,200 GBp at Credit Suisse
Upgrade
Associated British Foods upgraded to Outperform from Sector Perform at RBC » 04:39
07/06/20
07/06
04:39
07/06/20
04:39
ASBFY

Associated British Foods

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASBFY Associated British Foods
$0.00 /

+ (+0.00%)

07/03/20 Kepler Cheuvreux
Associated British Foods downgraded to Hold from Buy at Kepler Cheuvreux
07/03/20 Goldman Sachs
Associated British Foods downgraded to Neutral from Buy at Goldman Sachs
05/27/20 Credit Suisse
Associated British Foods price target lowered to 2,200 GBp at Credit Suisse
05/14/20 Redburn
Associated British Foods downgraded to Neutral from Buy at Redburn

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.